Login / Signup

Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.

Shelley A JohnsPatrick V StutzTasneem L TalibAndrea A CoheeKathleen A Beck-CoonLinda F BrownLaura R WilhelmPatrick O MonahanMichelle L LaPraddVictoria L ChampionKathy D MillerR Brian Giesler
Published in: Cancer (2019)
Group-based ACT is a feasible and promising treatment for FCR and associated outcomes in BCS that warrants testing in larger, fully powered trials.
Keyphrases
  • randomized controlled trial
  • study protocol
  • papillary thyroid
  • squamous cell
  • type diabetes
  • combination therapy
  • metabolic syndrome
  • childhood cancer
  • replacement therapy
  • glycemic control